chr6:88849583:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr6:88,849,583-88,876,066 |
| hg38 | chr6:88,139,864-88,166,347 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
| 0.120 | Catalepsy | NA | CTD_human | Detail | |
| 0.003 | ulcerative colitis | NA | BeFree,GAD | Detail | |
| 0.001 | colorectal carcinoma | Consistently, CpG methylation of rat Cnr1 promoter, miR23a and miR-301a, previou... | BeFree | 25533906 | Detail |
| 0.002 | Febrile Convulsions | NA | GAD | Detail | |
| 0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
| 0.001 | Coronary heart disease | NA | BeFree | Detail | |
| 0.002 | Crohn Disease | NA | GAD | Detail | |
| 0.006 | Mental Depression | NA | BeFree,GAD | Detail | |
| 0.002 | depressive disorder | NA | BeFree | Detail | |
| <0.001 | Diabetes | Diabetes alters the endocannabinoid system in a number of target organs, with pr... | BeFree | 25545857 | Detail |
| <0.001 | diabetes mellitus | Diabetes alters the endocannabinoid system in a number of target organs, with pr... | BeFree | 25545857 | Detail |
| 0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
| 0.003 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD | Detail | |
| <0.001 | Diabetic Nephropathy | NA | BeFree | Detail | |
| 0.080 | Diabetic Neuropathies | NA | RGD | Detail | |
| <0.001 | diabetic retinopathy | NA | BeFree | Detail | |
| <0.001 | Drug abuse | NA | BeFree | Detail | |
| <0.001 | Dyskinetic syndrome | NA | BeFree | Detail | |
| <0.001 | Eating Disorders | NA | BeFree | Detail | |
| <0.001 | Emotional Disturbances | NA | BeFree | Detail | |
| <0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
| 0.120 | endometriosis | NA | CTD_human | Detail | |
| 0.080 | Epilepsies, Partial | NA | RGD | Detail | |
| 0.120 | Epilepsy, Temporal Lobe | NA | CTD_human | Detail | |
| <0.001 | Fatty Liver, Alcoholic | NA | BeFree | Detail | |
| 0.080 | Fever | NA | RGD | Detail | |
| <0.001 | Glioma | NA | BeFree | Detail | |
| <0.001 | Globus Hystericus | NA | BeFree | Detail | |
| 0.002 | Heart Diseases | NA | GAD | Detail | |
| <0.001 | hepatitis C | NA | BeFree | Detail | |
| <0.001 | heroin dependence | NA | BeFree | Detail | |
| <0.001 | Hodgkin Disease | NA | BeFree | Detail | |
| 0.121 | Huntington disease | NA | BeFree,CTD_human | Detail | |
| 0.120 | Hyperalgesia | NA | CTD_human | Detail | |
| <0.001 | hyperinsulinism | NA | BeFree | Detail | |
| <0.001 | Hyperlipidemia | NA | BeFree | Detail | |
| 0.080 | Hypertensive disease | NA | RGD | Detail | |
| 0.200 | Hypotension | NA | CTD_human,RGD | Detail | |
| 0.120 | Hypothermia, natural | NA | CTD_human | Detail | |
| 0.005 | Inflammation | NA | GAD,LHGDN | Detail | |
| <0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
| 0.085 | Insulin resistance | NA | GAD,RGD | Detail | |
| 0.003 | irritable bowel syndrome | NA | BeFree,GAD | Detail | |
| 0.123 | liver cirrhosis | NA | CTD_human,LHGDN | Detail | |
| 0.120 | Liver Cirrhosis, Experimental | NA | CTD_human | Detail | |
| <0.001 | Liver diseases | NA | BeFree | Detail | |
| 0.002 | Low Back Pain | NA | GAD | Detail | |
| <0.001 | lymphoma | NA | BeFree | Detail | |
| 0.135 | Marijuana Abuse | In either case, greater CB1R receptor availability may contribute to the increas... | BeFree,CTD_human,GAD | 25107849 | Detail |
| <0.001 | melanoma | NA | BeFree | Detail | |
| 0.001 | Metabolic Diseases | NA | BeFree | Detail | |
| 0.120 | Movement Disorders | NA | CTD_human | Detail | |
| 0.125 | multiple sclerosis | NA | BeFree,CTD_human,GAD | Detail | |
| 0.120 | Muscle Spasticity | NA | CTD_human | Detail | |
| 0.002 | myocardial infarction | NA | GAD | Detail | |
| 0.080 | Myocardial Reperfusion Injury | NA | RGD | Detail | |
| <0.001 | Nausea and vomiting | NA | BeFree | Detail | |
| <0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| 0.200 | Nerve Degeneration | NA | CTD_human,RGD | Detail | |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | nicotine dependence | NA | BeFree | Detail | |
| 0.233 | obesity | This study demonstrates that treatment with CB1 antagonist AM251 improves renal ... | BeFree,CTD_human,GAD,RGD | 25804605 | Detail |
| 0.002 | Obesity, Morbid | NA | GAD | Detail | |
| <0.001 | optic neuritis | NA | BeFree | Detail | |
| 0.003 | Degenerative polyarthritis | NA | LHGDN | Detail | |
| 0.002 | osteoporosis | NA | GAD | Detail | |
| <0.001 | ovarian carcinoma | Results suggest CNR1 as a potential small synthetic peptide candidate for therap... | BeFree | 26504022 | Detail |
| 0.202 | Pain | NA | CTD_human,GAD,RGD | Detail | |
| 0.120 | Pancreatic Neoplasm | NA | CTD_human | Detail | |
| 0.120 | pancreatitis | NA | CTD_human | Detail | |
| 0.005 | Parkinson disease | NA | LHGDN | Detail | |
| 0.080 | Peptic Ulcer | NA | RGD | Detail | |
| <0.001 | polycystic ovary syndrome | Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat di... | BeFree | 25093427 | Detail |
| 0.003 | ectopic pregnancy | NA | BeFree,LHGDN | Detail | |
| 0.003 | Prostatic Neoplasms | NA | LHGDN | Detail | |
| 0.002 | Psychoses, Substance-Induced | NA | GAD | Detail | |
| <0.001 | Psychotic Disorders | Located on 6q15 and 1p36.11, cannabinoid receptor 1 (CNR1) and cannabinoid recep... | BeFree | 25014618 | Detail |
| 0.080 | Reperfusion Injury | NA | RGD | Detail | |
| <0.001 | Respiratory Tract Infections | NA | BeFree | Detail | |
| 0.120 | rhabdomyosarcoma | NA | BeFree,CTD_human | Detail | |
| 0.243 | schizophrenia | Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia i... | BeFree,CTD_human,GAD,LHGDN,RGD | 25014618 | Detail |
| 0.243 | schizophrenia | Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to pr... | BeFree,CTD_human,GAD,LHGDN,RGD | 25107849 | Detail |
| 0.003 | Schizophrenia, Disorganized | NA | BeFree,LHGDN | Detail | |
| <0.001 | paranoid schizophrenia | NA | BeFree | Detail | |
| 0.002 | Sciatica | NA | GAD | Detail | |
| 0.120 | Seizures | NA | CTD_human | Detail | |
| <0.001 | Shared Paranoid Disorder | NA | BeFree | Detail | |
| 0.080 | Shock, Hemorrhagic | NA | RGD | Detail | |
| 0.005 | Skin Neoplasms | NA | LHGDN | Detail | |
| 0.200 | status epilepticus | NA | CTD_human,RGD | Detail | |
| 0.005 | post-traumatic stress disorder | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
| 0.003 | substance dependence | NA | BeFree | Detail | |
| <0.001 | Substance Use Disorders | NA | BeFree | Detail | |
| 0.122 | Substance Withdrawal Syndrome | NA | CTD_human,GAD | Detail | |
| 0.002 | Tobacco use disorder | NA | GAD | Detail | |
| <0.001 | Gilles de la Tourette syndrome | NA | BeFree | Detail | |
| 0.001 | Unipolar Depression | NA | BeFree | Detail | |
| 0.122 | Weight Gain | NA | CTD_human,GAD | Detail | |
| <0.001 | Alcohol abuse | NA | BeFree | Detail | |
| <0.001 | Depressive Symptoms | NA | BeFree | Detail | |
| 0.003 | Migraine Disorders | NA | BeFree,GAD | Detail | |
| <0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
| <0.001 | lingual-facial-buccal dyskinesia | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | Anhedonia | Deficiency of CB1 receptor signaling is associated with anhedonia, anxiety, and ... | BeFree | 24882055 | Detail |
| <0.001 | alveolar rhabdomyosarcoma | NA | BeFree | Detail | |
| <0.001 | diastrophic dysplasia | NA | BeFree | Detail | |
| <0.001 | Abdominal discomfort | NA | BeFree | Detail | |
| 0.122 | Cocaine-Related Disorders | NA | CTD_human,GAD | Detail | |
| 0.120 | Substance-Related Disorders | NA | CTD_human | Detail | |
| <0.001 | Fibrosis, Liver | CB1 receptor was detected by immunohistochemistry in human liver fibrosis specim... | BeFree | 25713910 | Detail |
| 0.003 | Dyslipidemias | NA | BeFree,GAD | Detail | |
| 0.080 | Erectile dysfunction | NA | RGD | Detail | |
| 0.080 | Parkinsonian Disorders | NA | RGD | Detail | |
| <0.001 | Drug usage | NA | BeFree | Detail | |
| <0.001 | Coronary artery atheroma | NA | BeFree | Detail | |
| <0.001 | Impaired glucose tolerance | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
| <0.001 | Obesity, Abdominal | NA | BeFree | Detail | |
| 0.003 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree,LHGDN | Detail | |
| <0.001 | Impaired cognition | NA | BeFree | Detail | |
| <0.001 | Stable angina | NA | BeFree | Detail | |
| <0.001 | Nonorganic psychosis | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| 0.001 | Ichthyosis bullosa of Siemens | NA | BeFree | Detail | |
| 0.004 | Metabolic syndrome X | NA | BeFree,GAD | Detail | |
| 0.003 | ulcerative colitis | The CNR1 p.Thr453Thr polymorphism appears to modulate UC susceptibility and the ... | BeFree | 20195480 | Detail |
| <0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
| <0.001 | Hepatitis B, Chronic | NA | BeFree | Detail | |
| <0.001 | Hepatitis C, Chronic | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
| 0.233 | obesity | No significant difference was found between genotypes and alleles of DRD2 Taq1A ... | BeFree | 23057570 | Detail |
| 0.233 | obesity | The aim of our study was to investigate the influence of the missense polymorphi... | BeFree | 20204253 | Detail |
| 0.004 | Metabolic syndrome X | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabo... | BeFree | 20851297 | Detail |
| 0.001 | Coronary Arteriosclerosis | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the pr... | BeFree | 22138970 | Detail |
| 0.233 | obesity | We decided to investigate the role of the polymorphism (G1359A) of CB1 receptor ... | BeFree | 21666969 | Detail |
| 0.004 | coronary artery disease | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the pr... | BeFree | 22138970 | Detail |
| 0.233 | obesity | We decide to investigate the role of missense polymorphism (G1359A) of cannabino... | BeFree | 21543209 | Detail |
| 0.003 | Diabetes Mellitus, Non-Insulin-Dependent | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the pr... | BeFree | 22138970 | Detail |
| 0.233 | obesity | Previous studies demonstrated that G1359A polymorphism of cannabinoid receptor-1... | BeFree | 22138970 | Detail |
| 0.004 | coronary artery disease | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with corona... | BeFree | 22029183 | Detail |
| 0.004 | Metabolic syndrome X | Relation of G1359A polymorphism of the cannabinoid receptor (CB1) gene with meta... | BeFree | 21472841 | Detail |
| 0.001 | Coronary Arteriosclerosis | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with corona... | BeFree | 22029183 | Detail |
| 0.003 | Diabetes Mellitus, Non-Insulin-Dependent | The aim of our study was to investigate the influence of the missense polymorphi... | BeFree | 20204253 | Detail |
| 0.233 | obesity | We decide to investigate the role of polymorphism (G1359A) of (CNR1) gene on met... | BeFree | 23337343 | Detail |
| 0.001 | Coronary heart disease | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the pr... | BeFree | 22138970 | Detail |
| 0.001 | Coronary heart disease | G1359A polymorphism in the cannabinoid receptor-1 gene is associated with corona... | BeFree | 22029183 | Detail |
| <0.001 | prostate carcinoma | NA | BeFree | Detail | |
| 0.003 | cocaine dependence | NA | BeFree,GAD | Detail | |
| <0.001 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Tardive Dyskinesia | NA | BeFree | Detail | |
| <0.001 | colon carcinoma | Interestingly, CNR1 gene was less expressed in Caco-2 cells when compared to nor... | BeFree | 25533906 | Detail |
| <0.001 | colon carcinoma | AM251 is a cannabinoid type 1 (CB1) receptor antagonist/inverse agonist with off... | BeFree | 25974027 | Detail |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| 0.003 | Substance abuse problem | NA | BeFree,GAD | Detail | |
| <0.001 | Polysubstance abuse | NA | BeFree | Detail | |
| <0.001 | perfectionism | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of ovary | Results suggest CNR1 as a potential small synthetic peptide candidate for therap... | BeFree | 26504022 | Detail |
| <0.001 | Mammary Carcinoma, Human | NA | BeFree | Detail | |
| 0.001 | major depressive disorder | NA | BeFree | Detail | |
| <0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
| 0.004 | drug dependence | NA | BeFree,GAD | Detail | |
| <0.001 | Autism Spectrum Disorders | NA | BeFree | Detail | |
| 0.004 | colorectal cancer | Consistently, CpG methylation of rat Cnr1 promoter, miR23a and miR-301a, previou... | BeFree,GAD | 25533906 | Detail |
| <0.001 | Non-Malignant Ascites Adverse Event | Vehicle, archidonyl-2-chloroethylamide (ACEA, CB1R agonist), JWH133 (CB2R agonis... | BeFree | 24953022 | Detail |
| <0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| <0.001 | NEUROTICISM | NA | BeFree | Detail | |
| 0.004 | coronary artery disease | NA | BeFree,LHGDN | Detail | |
| 0.003 | liver carcinoma | NA | LHGDN | Detail | |
| <0.001 | bulimia nervosa | NA | BeFree | Detail | |
| 0.002 | Weight Loss Adverse Event | NA | GAD | Detail | |
| 0.002 | Weight Gain Adverse Event | NA | GAD | Detail | |
| 0.002 | Chronic ulcerative colitis | NA | GAD | Detail | |
| 0.002 | IV drug use | NA | GAD | Detail | |
| 0.002 | Abdominal Pain | NA | GAD | Detail | |
| 0.002 | Acute Disease | NA | GAD | Detail | |
| <0.001 | alcohol use disorder | NA | BeFree | Detail | |
| 0.003 | Alcohol Withdrawal Delirium | NA | BeFree,LHGDN | Detail | |
| 0.005 | Alcoholic Intoxication, Chronic | NA | BeFree,GAD | Detail | |
| <0.001 | Angina, Unstable | NA | BeFree | Detail | |
| <0.001 | anorexia nervosa | NA | BeFree | Detail | |
| 0.002 | antisocial personality disorder | NA | GAD | Detail | |
| 0.122 | Anxiety Disorders | Deficiency of CB1 receptor signaling is associated with anhedonia, anxiety, and ... | BeFree,CTD_human | 24882055 | Detail |
| 0.122 | Anxiety Disorders | Hsa-miR-4717-5p showed the most robust effect on RGS2 and regulated two other ca... | BeFree,CTD_human | 25847876 | Detail |
| <0.001 | arteriosclerosis | NA | BeFree | Detail | |
| 0.003 | rheumatoid arthritis | NA | LHGDN | Detail | |
| 0.080 | Ascites | NA | RGD | Detail | |
| <0.001 | Astrocytoma | NA | BeFree | Detail | |
| <0.001 | atherosclerosis | NA | BeFree | Detail | |
| 0.002 | autistic disorder | NA | GAD | Detail | |
| 0.001 | Mental disorders | Located on 6q15 and 1p36.11, cannabinoid receptor 1 (CNR1) and cannabinoid recep... | BeFree | 25014618 | Detail |
| 0.003 | bipolar disorder | NA | BeFree,GAD | Detail | |
| <0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
| 0.004 | cannabis dependence | NA | BeFree,GAD | Detail | |
| <0.001 | Malignant tumor of colon | Interestingly, CNR1 gene was less expressed in Caco-2 cells when compared to nor... | BeFree | 25533906 | Detail |
| <0.001 | Malignant tumor of colon | AM251 is a cannabinoid type 1 (CB1) receptor antagonist/inverse agonist with off... | BeFree | 25974027 | Detail |
| <0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Consistently, CpG methylation of rat Cnr1 promoter, miR23a and miR-301a, previously shown to be invo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Diabetes alters the endocannabinoid system in a number of target organs, with previous research char... | DisGeNET | Detail |
| Diabetes alters the endocannabinoid system in a number of target organs, with previous research char... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In either case, greater CB1R receptor availability may contribute to the increased susceptibility of... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study demonstrates that treatment with CB1 antagonist AM251 improves renal outcomes in obese ra... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Results suggest CNR1 as a potential small synthetic peptide candidate for therapeutic strategies aga... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Located on 6q15 and 1p36.11, cannabinoid receptor 1 (CNR1) and cannabinoid receptor 2 (CNR2) genes a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean populatio... | DisGeNET | Detail |
| Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Deficiency of CB1 receptor signaling is associated with anhedonia, anxiety, and persistence of negat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CB1 receptor was detected by immunohistochemistry in human liver fibrosis specimens. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The CNR1 p.Thr453Thr polymorphism appears to modulate UC susceptibility and the CD phenotype. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| No significant difference was found between genotypes and alleles of DRD2 Taq1A and DRD2 Taq1B polym... | DisGeNET | Detail |
| The aim of our study was to investigate the influence of the missense polymorphism (G1359A) of CB1 r... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the ... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary a... | DisGeNET | Detail |
| We decided to investigate the role of the polymorphism (G1359A) of CB1 receptor gene on adipocytokin... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary a... | DisGeNET | Detail |
| We decide to investigate the role of missense polymorphism (G1359A) of cannabinoid receptor 1 gene o... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary a... | DisGeNET | Detail |
| Previous studies demonstrated that G1359A polymorphism of cannabinoid receptor-1 (CNR1) was associat... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in... | DisGeNET | Detail |
| Relation of G1359A polymorphism of the cannabinoid receptor (CB1) gene with metabolic syndrome by AT... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in... | DisGeNET | Detail |
| The aim of our study was to investigate the influence of the missense polymorphism (G1359A) of CB1 r... | DisGeNET | Detail |
| We decide to investigate the role of polymorphism (G1359A) of (CNR1) gene on metabolic parameters an... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary a... | DisGeNET | Detail |
| G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interestingly, CNR1 gene was less expressed in Caco-2 cells when compared to normal colon mucosa cel... | DisGeNET | Detail |
| AM251 is a cannabinoid type 1 (CB1) receptor antagonist/inverse agonist with off-target antitumor ac... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Results suggest CNR1 as a potential small synthetic peptide candidate for therapeutic strategies aga... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Consistently, CpG methylation of rat Cnr1 promoter, miR23a and miR-301a, previously shown to be invo... | DisGeNET | Detail |
| Vehicle, archidonyl-2-chloroethylamide (ACEA, CB1R agonist), JWH133 (CB2R agonist), and AM630 (CB2R ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Deficiency of CB1 receptor signaling is associated with anhedonia, anxiety, and persistence of negat... | DisGeNET | Detail |
| Hsa-miR-4717-5p showed the most robust effect on RGS2 and regulated two other candidate genes of anx... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Located on 6q15 and 1p36.11, cannabinoid receptor 1 (CNR1) and cannabinoid receptor 2 (CNR2) genes a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interestingly, CNR1 gene was less expressed in Caco-2 cells when compared to normal colon mucosa cel... | DisGeNET | Detail |
| AM251 is a cannabinoid type 1 (CB1) receptor antagonist/inverse agonist with off-target antitumor ac... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386513644 dbSNP
- Genome
- hg19
- Position
- chr6:88,849,583-88,876,066
- Variant Type
- snv
Genome browser